如何治愈自身免疫性淋巴结膜炎和足细胞病变
Hans-Joachim Anders1, Stefanie Steiger1, Paola Romagnani2
1Department of Medicine IV, Hospital of Ludwig Maximilians University, Munich, Germany.
Journal of the American Society of Nephrology : JASN
|October 10, 2025
概括
这一综述重新定义了自身免疫性病的治疗方法,如血球炎 (GN) 和 podocytopathies. 它优先考虑疾病的急性和潜在的自身免疫机制,而不是蛋白尿,用于量身定制的免疫治疗和慢性病 (CKD) 管理.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 内部医学 内部医学
背景情况:
- 自身免疫性淋巴结膜炎 (GN) 和 podocytopathies 是免疫介导的脏疾病.
- 目前的预后和免疫治疗强度依赖于蛋白尿和组织型.
- 氨酶系统和SGLT2抑制剂通常被认为仅仅是支持性护理.
研究的目的:
- 根据共享的病理生理学,完善基于GN和podocytopathies的治疗概念.
- 确定疾病敏度作为治疗强度的主要决定因素.
- 将慢性病 (CKD) 管理纳入治疗优先事项.
主要方法:
- 审查当前对自身免疫性GN和 podocytopathies 的理解.
- 分析疾病急性 (快速进展,复发,慢性) 以指导治疗优先事项.
- 基于疾病复杂性的B细胞向疗法和组合疗法的评估.
- 纳入KDIGO CKD风险矩阵和管理建议.
主要成果:
- 疾病的急性决定了不同的治疗优先事项:快速进展的GN的即时补充抑制/抗体去除,单克隆复发性疾病的长期B细胞向单疗法,以及多抗原疾病的组合疗法.
- 慢性病 (CKD) 管理是一个关键的优先事项,在慢性病中成为首要的,在复发性病/细胞病变中成为次要的.
- 仅仅蛋白尿是治疗决策的不足,因为它可以表明疾病活动,CKD,或两者兼而有之.
结论:
- 应根据疾病的急性程度和潜在的自身免疫病理机制,重新定义 GN 和 podocytopathies 的治疗策略.
- 免疫疗法强度应根据特定疾病特征量身定制,而不仅仅是蛋白尿水平.
- 综合性CKD护理对于自身免疫性病患者的更好的长期结果至关重要.
相关概念视频
01:28Chronic Kidney Disease III: Interprofessional Care
339
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
01:26Nephrotic Syndrome II : Assessment and Medical Management
200
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
200
01:24Nephrotic Syndrome III : Nursing Management
279
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
279
01:29Autoimmune Disorders
1.5K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
1.5K
01:20Acute Kidney Injury V: Interprofessional Care
296
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
296
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
488
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
488